Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema

J Comp Eff Res. 2024 May;13(5):e230165. doi: 10.57264/cer-2023-0165. Epub 2024 Mar 28.
No abstract available

Publication types

  • Letter
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Angioedemas, Hereditary* / drug therapy
  • Antibodies, Monoclonal* / therapeutic use
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Complement C1 Inhibitor Protein / therapeutic use
  • Humans
  • Meta-Analysis as Topic
  • Network Meta-Analysis

Substances

  • Antibodies, Monoclonal, Humanized
  • lanadelumab
  • Antibodies, Monoclonal
  • Complement C1 Inhibitor Protein